Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS as Continuation Treatment to Sustain Remission After Electroconvulsive Therapy in Depression

NCT02886858 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT02886858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02886858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS as Continuation Treatment to Sustain Remission After Electroconvulsive Therapy in Depression
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Terminated
Start date
February 13, 2017
Completion date
April 19, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression